Sonoma Biotherapeutics Stock
Sonoma Biotherapeutics is inventing the future of living therapies for autoimmune disease — safe, effective treatments as unique as each individual patient. Regulatory T cell therapies that harness a patient’s own immune cells, powerful next generation gene editing techniques and advanced manufacturing and quality assurance processes. Sonoma’s mission is to create a best-in-class regulatory T cell therapy that delivers long-lasting, highly efficacious treatments leading to cures across a spectrum of autoimmune and degenerative diseases.
Sign up for SecondMarket® to view the market and buy or sell Sonoma Biotherapeutics Stock
Buy + SellSee Sonoma Biotherapeutics Valuations + Financials
*Sample data + company shown for illustrative purposes only
Gain insights Into Sonoma Biotherapeutics Stock Valuation + Share Prices
View real-time Tape D® data on Sonoma Biotherapeutics stock including most recent valuation and historical share price information.
Are you an institutional investor or employee shareholder? Sign up to the SecondMarket trading platform.
Get Started
Sonoma Biotherapeutics Management Team
-
Co-Founder, Scientific Advisor
Alexander Rudensky
-
Co-Founder, Scientific Advisor
Qizhi Tang
-
Co-Founder, CEO, President, Director
Jeffrey Bluestone
-
Director
Toni Hoover
-
Director
Maggie Wilderotter
-
Director
Terry Rosen
-
Director
John C. Davis
-
Director
Carlos Solórzano
-
Chairman
Richard Klausner
-
Co-Founder, Scientific Advisor
Fred Ramsdell
Sonoma Biotherapeutics Major Investors
-
Vertex Ventures
-
Piper Heartland Healthcare Capital
-
Osage University Partners
-
Octagon Investments
-
NS Investment
-
Mirae Asset Capital
-
Milky Way Ventures
-
Lyell Immunopharma
-
Lilly Asia Ventures
-
LifeForce Capital
-
JDRF T1D Fund
-
Google Ventures
-
Frazier Healthcare Ventures
-
Fidelity
-
Deep Track Capital
-
Casdin Capital
-
Avidity Partners
-
ArrowMark Partners
-
ARCH Venture Partners
-
Ally Bridge Group
-
Alexandria Venture Investments
-
8VC
Learn More About Sonoma Biotherapeutics Stock
Buy Sonoma Biotherapeutics Stock
01Sonoma Biotherapeutics stock does not trade on public stock exchanges. Sonoma Biotherapeutics stock is considered a private security and you need to be an accredited investor to trade shares. To invest in Sonoma Biotherapeutics stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.
Learn more about the secondary market for private company shares on the investors page.
Sell Sonoma Biotherapeutics Stock
02Sonoma Biotherapeutics Stock does not trade on public stock exchanges. In order to sell Sonoma Biotherapeutics shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.
Learn more about NPM services for selling privately held stock on the Employee Shareholders page.
Read more about how to sell private company stock on the private secondary market:
Sonoma Biotherapeutics Stock Price
03Sonoma Biotherapeutics does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the Tape D™ database from Nasdaq Private Market, you can view Sonoma Biotherapeutics share price and other valuable private market data.
Read more about secondary market private company stock prices:
Sonoma Biotherapeutics Stock Ticker Symbol
04There is no ticker symbol for Sonoma Biotherapeutics stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.
Criteria to Sell Sonoma Biotherapeutics Stock
05Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell Sonoma Biotherapeutics stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.
Learn more about selling privately held stock on the Employee Shareholders page.
Read more about how to sell shares of a private company and eligibility for selling privately held stock:
Criteria to Buy or Invest in Sonoma Biotherapeutics Stock
06Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in Sonoma Biotherapeutics stock, you need to be an accredited entity or institutional investor.
Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.
Sonoma Biotherapeutics Stock Settlement
07Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.
To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.
Sonoma Biotherapeutics IPO
08Sonoma Biotherapeutics is a private company and has not had an IPO. There is currently no Sonoma Biotherapeutics IPO price. Get started to begin exploring the Nasdaq Private Market Tape D™ database and gain access to actionable data related to Sonoma Biotherapeutics IPO.
Learn more about Tape D™ private company stock data for institutional investors on the on the Tape D™ Product Page.
Sign up for SecondMarket® to view the market and buy or sell Sonoma Biotherapeutics Stock
Buy + Sell*All trademarks are the property of their respective owner(s). Unless expressly stated otherwise, companies listed on this site are not sponsoring, endorsing, or otherwise affiliated with, Nasdaq Private Market, LLC, and none of the statements on this website should be attributed to a listed company.
